Tero Aittokallio

UNSTABLE LDL - NOVEL MECHANISM OF ATHEROGENESIS AND LINK TO CARDIOVASCULAR DEATHS (2016)

Atherosclerosis

Ruuth M, Nguyen SD, Vihervaara T, Laajala TD, Uusitupa M, Schwab U, Savolainen M, Sinisalo J, Aittokallio T, Kakela R, Jauhiainen M, Kovanen P, Oorni K

(Muu (O2))

Novel therapeutic possibilities for chemorefractory ovarian cancer patients identified by functional ex vivo drug sensitivity testing of primary cells (2016)

International Journal of Gynecological Cancer

Murumagi A, Hirasawa A, Khan S, Arjama M, Pellinen T, Koivisto-Korander R, Leminen A, Magi A, Aittokallio T, Butzow R, Kallioniemi O

(Muu (O2))

Identification of selective cytotoxic and synthetic lethal drug responses in triple negative breast cancer cells (2016)

Molecular Cancer

Gautam P, Karhinen L, Szwajda A, Jha SK, Yadav B, Aittokallio T, Wennerberg K

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Pro-apoptotic functions of AMPK revealed by Myc (2016)

Molecular Cancer Research

Haikala HM, Marques E, Eskelinen V, Viheriaranta-Nieminen A, Saarikoski S, Nevalaita L, Kovanen P, Heikkila P, Leidenius M, Laajala D, Aittokallio T, Munne P, Klefstrom J

(Muu (O2))

Characterization of ascites and tumor-derived ovarian cancer stem-like cells (2016)

Clinical Cancer Research

Kaipio K, Chen P, Huhtinen K, Mikkonen P, Ostling P, Mpindi JP, Lehtinen L, Roering P, Korpela T, Wennerberg K, Yadav B, Aittokallio T, Kulesskiy E, Hynninen J, Auranen A, Grenman S, Hautaniemi S, Carpen O

(Muu (O2))

Transcriptional response networks for elucidating mechanisms of action of multitargeted agents (2016)

Drug Discovery Today

Kibble M, Khan SA, Saarinen N, Iorio F, Saez-Rodriguez J, Mäkelä S, Aittokallio T

(Vertaisarvioitu katsausartikkeli tieteellisessä aikakauslehdessä (A2))

Optimized design and analysis of preclinical intervention studies in vivo (2016)

Scientific Reports

Laajala TD, Jumppanen M, Huhtaniemi R, Fey V, Kaur A, Knuuttila M, Aho E, Oksala R, Westermarck J, Mäkelä S, Poutanen M*, Aittokallio T*

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Multi-Omics Studies towards Novel Modulators of Influenza A Virus-Host Interaction (2016)

Viruses

Soderholm S, Fu Y, Gaelings L, Belanov S, Yetukuri L, Berlinkov M, Cheltsov AV, Anders S, Aittokallio T, Nyman TA, Matikainen S, Kainov DE

(Vertaisarvioitu katsausartikkeli tieteellisessä aikakauslehdessä (A2))

Comprehensive drug testing of patient derived conditionally reprogrammed cells from castration -resistant prostate cancer (2016)

Cancer Research

Saeed K, Rahkama V, Eldfors S, Bychkov D, Mpindi JP, Yadav B, Aittokallio T, Horvath P, Peehl D, Paavolainen L, Heckman C, Wennerberg K, Mirtti T, Rannikko A, Kallioniemia I, Ostling P, Af Hallstrom T

(Muu (O2))

Consistency in drug response profiling (2016)

Nature

Mpindi JP, Yadav B, Ostling P, Gautam P, Malani D, Murumagi A, Hirasawa A, Kangaspeska S, Wennerberg K, Kallioniemi O, Aittokallio T

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Ota yhteyttä

Linkit

Julkaisut

Järjestä:

UNSTABLE LDL - NOVEL MECHANISM OF ATHEROGENESIS AND LINK TO CARDIOVASCULAR DEATHS (2016)

Novel therapeutic possibilities for chemorefractory ovarian cancer patients identified by functional ex vivo drug sensitivity testing of primary cells (2016)

Identification of selective cytotoxic and synthetic lethal drug responses in triple negative breast cancer cells (2016)

Pro-apoptotic functions of AMPK revealed by Myc (2016)

Characterization of ascites and tumor-derived ovarian cancer stem-like cells (2016)

Transcriptional response networks for elucidating mechanisms of action of multitargeted agents (2016)

Optimized design and analysis of preclinical intervention studies in vivo (2016)

Multi-Omics Studies towards Novel Modulators of Influenza A Virus-Host Interaction (2016)

Comprehensive drug testing of patient derived conditionally reprogrammed cells from castration -resistant prostate cancer (2016)

Consistency in drug response profiling (2016)